163 related articles for article (PubMed ID: 10782412)
1. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation.
Garcia A; Bussaglia E; Machin P; Matias-Guiu X; Prat J
Int J Gynecol Pathol; 2000 Apr; 19(2):152-7. PubMed ID: 10782412
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: a molecular, immunohistochemical, and clinicopathologic study.
Gras E; Pons C; Machin P; Matias-Guiu X; Prat J
Int J Gynecol Pathol; 2001 Oct; 20(4):335-40. PubMed ID: 11603216
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
[TBL] [Abstract][Full Text] [Related]
4. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
[TBL] [Abstract][Full Text] [Related]
6. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior.
Otis CN; Krebs PA; Quezado MM; Albuquerque A; Bryant B; San Juan X; Kleiner D; Sobel ME; Merino MJ
Hum Pathol; 2000 Feb; 31(2):233-8. PubMed ID: 10685639
[TBL] [Abstract][Full Text] [Related]
8. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
10. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of synchronous mucinous tumors of the ovary and appendix.
Chuaqui RF; Zhuang Z; Emmert-Buck MR; Bryant BR; Nogales F; Tavassoli FA; Merino MJ
Hum Pathol; 1996 Feb; 27(2):165-71. PubMed ID: 8617458
[TBL] [Abstract][Full Text] [Related]
12. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 7q22 and mutation analysis of the CDP gene in human epithelial ovarian tumors.
Neville PJ; Thomas N; Campbell IG
Int J Cancer; 2001 Feb; 91(3):345-9. PubMed ID: 11169958
[TBL] [Abstract][Full Text] [Related]
14. Loss of cables, a novel gene on chromosome 18q, in ovarian cancer.
Dong Q; Kirley S; Rueda B; Zhao C; Zukerberg L; Oliva E
Mod Pathol; 2003 Sep; 16(9):863-8. PubMed ID: 13679449
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
[TBL] [Abstract][Full Text] [Related]
17. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types.
Okada S; Tsuda H; Takarabe T; Yoshikawa H; Taketani Y; Hirohashi S
Jpn J Cancer Res; 2002 Jul; 93(7):798-806. PubMed ID: 12149146
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
[TBL] [Abstract][Full Text] [Related]
19. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
20. Genomic structure of chromosome 17 deletions in BRCA1-associated ovarian cancers.
Chisholm KM; Goff BA; Garcia R; King MC; Swisher EM
Cancer Genet Cytogenet; 2008 May; 183(1):41-8. PubMed ID: 18474296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
